Clinical Trials Directory

Trials / Unknown

UnknownNCT05144451

Transcranial Doppler During Liver Transplantation

Transcranial Doppler and Neurological Complications After Liver Transplantation

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Mansoura University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a prospective study that would investigate the transcranial doppler (TCD) changes during the living donor liver transplantation and the association between the TCD changes and the post-transplant neurological complications.

Detailed description

Objectives: Participants \& Setting: Intervention \& Measurements: Sample size:

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTTranscranial DopplerTranscranial Doppler-derived parameters; pulsatility index (PI), resistance index (RI), mean flow velocity (Vmean) will be recorded before induction of anesthesia (T1). After induction, TCD parameters, Hemodynamic variables including heart rate (HR), invasive mean arterial blood pressure (MAP), and central venous pressure (CVP) together with Arterial blood gases (ABG analysis with values of PH, PCO2, PO2, blood oxygen saturation SO2 and bicarbonate HCO3), end-tidal carbon dioxide (ETCO2) and body temperature will be recorded too. Just before skin incision (T2), at the end of anhepatic phase 5 minutes before reperfusion (T3), 5 minutes after reperfusion (T4) and at the end of surgery (T5). Postoperatively at ICU, TCD parameters, Hemodynamic variables, and ABG will be obtained 24 hours postoperative (T6) and at discharge from ICU (T7).

Timeline

Start date
2021-11-28
Primary completion
2023-11-28
Completion
2024-04-28
First posted
2021-12-03
Last updated
2022-04-14

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05144451. Inclusion in this directory is not an endorsement.